HIF-1α expression has also been reported to be associated with worse overall and event-free survival in a Ph-negative pre-B ALL model, implicating that inhibition of AKT signaling or blockade of HIF-1α-mediated pro-survival signaling events may improve clinical outcomes in pre-B ALL (91). Here, AKT1 is linked to acute lymphoblastic leukemia.